Myovant Sciences Ltd Stock News

Myovant Sciences (MYOV), a healthcare company focused on developing innovative treatments for women's health and prostate cancer, and Gedeon Richter Plc., a major pharmaceutical company in Central Eas

After starting the week ended March 28 on the backfoot, biotech stocks recovered through the week. Activity in the space remained light, although coronavirus (COVID-19) news flow continued to dominate

Tables of the top insider purchases and sales filed with the SEC on 3/26/20, based on dollar value. Dollar values often do not equate with significance when it

Myovant Sciences Ltd (NYSE:MYOV) major shareholder Chemical Co. Ltd. Sumitomo purchased 108,100 shares of the company’s stock in a transaction dated Wednesday, March 25th. The shares were acquired a

ValuEngine upgraded shares of Myovant Sciences (NYSE:MYOV) from a buy rating to a strong-buy rating in a research note released on Tuesday, ValuEngine reports. MYOV has been the topic of several other

Shares of Myovant Sciences Ltd (NYSE:MYOV) were up 7.4% during mid-day trading on Thursday following insider buying activity. The stock traded as high as $8.35 and last traded at $8.11, approximately

Tables of the top insider purchases and sales filed with the SEC on 3/24/20, based on dollar value. Dollar values often do not equate with significance when it

Myovant Sciences Ltd (NYSE:MYOV) major shareholder Chemical Co. Ltd. Sumitomo purchased 405,100 shares of the firm’s stock in a transaction dated Monday, March 23rd. The shares were purchased at an

Equities research analysts predict that Myovant Sciences Ltd (NYSE:MYOV) will post ($0.79) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Zero analysts have issue

State Street Corp lifted its position in Myovant Sciences Ltd (NYSE:MYOV) by 16.4% in the fourth quarter, HoldingsChannel reports. The firm owned 66,956 shares of the company’s stock after buying an

Myovant Sciences Ltd (NYSE:MYOV) major shareholder Chemical Co. Ltd. Sumitomo purchased 387,800 shares of the stock in a transaction on Thursday, March 19th. The stock was acquired at an average cost

Myovant Sciences Ltd (NYSE:MYOV) major shareholder Chemical Co. Ltd. Sumitomo bought 193,900 shares of the company’s stock in a transaction dated Monday, March 16th. The stock was bought at an avera

Barclays PLC raised its stake in Myovant Sciences Ltd (NYSE:MYOV) by 132.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional i

Myovant Sciences Ltd (NYSE:MYOV) shares were down 8.4% during trading on Wednesday . The stock traded as low as $8.65 and last traded at $8.70, approximately 854,304 shares traded hands during trading

Fmr LLC acquired a new position in Myovant Sciences Ltd (NYSE:MYOV) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). Th